Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael Northcutt"'
Publikováno v:
Case Reports in Hepatology, Vol 2019 (2019)
We describe a patient with compensated cirrhosis and portal hypertension who underwent continuous flow LVAD implantation. Shortly after LVAD implantation, the patient developed new onset bleeding esophageal varices and ultimately had a fatal outcome.
Externí odkaz:
https://doaj.org/article/a28032a05b6c476cb1139ac6e6079e10
Autor:
Michael Northcutt, Zhuqing Shi, Michael Zijlstra, Ayush Shah, Siqun Zheng, Eugene Yen, Omar Khan, Mohammad Imran Beig, Polina Imas, Adam Vanderloo, Obaid Ansari, Jianfeng Xu, Jay Goldstein
Background: SNP-based polygenic risk scoring is predictive of colorectal cancer (CRC) risk. However, few studies have investigated the association of genetic risk score (GRS) with detection of adenomatous polyps at screening colonoscopy. Methods: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2148e7fc91d2dde205a66c78e3e3467
https://doi.org/10.21203/rs.3.rs-62371/v1
https://doi.org/10.21203/rs.3.rs-62371/v1
Autor:
Yi-Ting Tsai, Lee A. Denson, Fred D. Finkelman, Kimberly Jackson, Michael J. Rosen, Phillip Minar, Marat Khodoun, Michael Northcutt
We have previously shown that CD64 surface expression on circulating neutrophils is significantly elevated in children with newly diagnosed Crohn's disease (CD). Our primary aim was to investigate whether elevations in neutrophil CD64 in asymptomatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b38788f2061c3e300a3e220e0fcadaf
https://europepmc.org/articles/PMC5117809/
https://europepmc.org/articles/PMC5117809/
Publikováno v:
The West Virginia medical journal. 110(3)
The immune-modulating drug, infliximab, is approved for Inflammatory Bowel Disease (IBD) treatment in children. Chronic therapy with infliximab is associated with the development of early and delayed infusion reactions. We reviewed our experience wit